Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia

Published:2009-05-14 Issue:10 Volume:23 Page:1771-1778
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Giannopoulos K,Dmoszynska A,Kowal M,Wąsik-Szczepanek E,Bojarska-Junak A,Rolinski J,Döhner H,Stilgenbauer S,Bullinger L

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu200998.pdf

Reference34 articles.

1. Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR et al. Biology and treatment of chronic lymphocytic leukemia. Hematology (Am Soc Hematol Educ Program) 2003, 153–175.

2. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916.

3. Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–1416.

4. Montserrat E . New prognostic markers in CLL. Hematology (Am Soc Hematol Educ Program) 2006, 279–284.

5. Zenz T, Dohner H, Stilgenbauer S . Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007; 20: 439–453.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy;Pharmaceutics;2023-03-27

2. Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms;Frontiers in Immunology;2022-10-12

3. TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy;Medical Oncology;2022-09-29

4. Super-Enhancer–Associated nine-gene prognostic score model for prediction of survival in chronic lymphocytic leukemia patients;Frontiers in Genetics;2022-09-15

5. TNFR2: Role in Cancer Immunology and Immunotherapy;ImmunoTargets and Therapy;2021-04